Location History:
- Mountain View, CA (US) (2016)
- Sunnyvale, CA (US) (2019 - 2021)
- St. Louis, MO (US) (2020 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Steve Oh: Innovator in Nucleic Acid Technologies
Introduction
Steve Oh is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid technologies. With a total of six patents to his name, Steve has developed innovative methods that enhance the efficiency of nucleic acid manipulation.
Latest Patents
Among his latest patents, Steve has developed methods for depleting a target nucleic acid in a sample. These methods involve contacting the target nucleic acid with two or more polymers that specifically hybridize to it, followed by cleaving the hybridized regions to effectively deplete the target nucleic acid. Additionally, he has created methods for adding adapters to nucleic acids. This process includes combining a template ribonucleic acid (RNA) with a template switch oligonucleotide and a sequencing platform adapter construct, resulting in a product nucleic acid that incorporates both the template RNA and the oligonucleotide.
Career Highlights
Steve Oh is currently employed at Takara Bio USA, Inc., where he continues to push the boundaries of nucleic acid research. His work has been instrumental in developing practical applications for his inventions, which are crucial for advancements in genetic research and diagnostics.
Collaborations
Steve has collaborated with notable colleagues, including Andrew Alan Farmer and Ian B Oglesby. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Steve Oh is a key figure in the field of nucleic acid technologies, with a strong portfolio of patents that reflect his innovative spirit. His contributions are paving the way for future advancements in molecular biology.